Adicet Bio
ACET
ACET
64 hedge funds and large institutions have $55.4M invested in Adicet Bio in 2024 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 16 increasing their positions, 23 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
30% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 23
32% less capital invested
Capital invested by funds: $81.6M → $55.4M (-$26.2M)
48% less call options, than puts
Call options by funds: $27K | Put options by funds: $52K
Holders
64
Holding in Top 10
2
Calls
$27K
Puts
$52K
Top Buyers
| 1 | +$177K | |
| 2 | +$168K | |
| 3 | +$155K | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$118K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$109K |
Top Sellers
| 1 | -$303K | |
| 2 | -$251K | |
| 3 | -$215K | |
| 4 |
Millennium Management
New York
|
-$139K |
| 5 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
-$125K |